Supporters

At Bristol Myers Squibb, our mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. We are motivated by the power of science, with a legacy of pursuing bold science across oncology, hematology, cardiovascular, immunology and neuroscience. We’re accelerating the development of new medicines with differentiated research platforms and leading technology to define what’s possible for the future of medicine and the patients we serve.

At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at https://www.jnj.com/innovativemedicine/emea/.
Follow us at https://www.linkedin.com/company/jnj-innovative-medicine-emea/ for our latest news.

STARS is a nonprofit organization dedicated to improving the lives of individuals who stutter by advancing neuroscience-based research and comprehensive treatment methods. STARS is focused on uncovering the neurological causes of stuttering, with the goal of increasing global awareness and understanding of the condition. Through groundbreaking research and innovation, we aim to reduce the stigma and discrimination faced by those who stutter. STARS is committed to educating the greater healthcare community to facilitate access for individuals who stutter to receive comprehensive therapies. We are committed to developing new treatments today while working towards discovering cures for tomorrow. Address: 3151 Airway Avenue Building A3. Costa Mesa, CA 92626 USA
Contact Person: Gerald A Maguire MD
Email: GMaguireMD@stutteringresearch.org

Newron Pharmaceuticals SpA is a biopharmaceutical company dedicated to developing innovative therapies for patients with diseases of the central and peripheral nervous system. Founded in 1999 and headquartered in Bresso, near Milan, Italy, with a subsidiary in Morristown, NJ, USA, the company focuses on addressing significant unmet medical needs in difficult-to-treat conditions such as Treatment-resistant schizophrenia, Parkinson’s disease, and other areas where therapeutic innovation has been limited for decades. Building on >25 years of proprietary scientific research and clinical development, Newron’s multidisciplinary team of approximately 30 scientists, researchers, and clinicians works to advance novel drug candidates from discovery through clinical development toward commercialization. Address: via Antonio Meucci 3 20091 Bresso (MI) Italy

Viatris is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address global healthcare needs. With a mission to empower people worldwide to live healthier at every stage of life, we provide access at scale—supplying medicines to approximately 1 billion patients around the world.

Visit the Wisepress stand to view our extensive range of books and journals relevant to this conference. We work with multiple publishers to ensure that our books are the best available in your specialism.
Wisepress.com is Europe’s leading conference bookseller, attending 150 conferences a year with titles also available on our online bookshop at www.wisepress.com. Want to make a bulk order? Contact us at bookshop@wisepress.com